Posted on 1/12/21
Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech . . .
Posted on 1/12/21
Vedanta Biosciences Announces $25 Million Investment from Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, . . .
Posted on 1/12/21
Is Johnson & Johnson an Underdog in the Coronavirus Vaccine Race?
The past month has been critical in the quest for a COVID-19 vaccine. Pfizer and its partner BioNTech earned emergency use authorization (EUA) Dec. 11 from . . .
Posted on 1/12/21
Bristol Myers Squibb Announces $2 Billion Incremental Share Repurchase Authorization
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has authorized incremental share repurchases of up to an additional $2 billion . . .
Posted on 1/11/21
Ashikari Breast Center Joins Northwell Health Physician Partners
Breast surgeons Dr. Andrew Ashikari and Dr. Pond Kelemen will see patients at Northern Westchester Hospital and Phelps Hospital (L-R) Dr. Andrew Ashikari and Dr. Pond . . .
Posted on 1/11/21
My Best Biotech Stock for 2021
It's only been a couple of years since BridgeBio Pharma (NASDAQ:BBIO) made its stock market debut, and the company already has two new drug applications under . . .
Posted on 1/11/21
Why Pfizer Was a Surprising Loser in 2020 but Could Win Big Time in 2021
In theory, 2020 should have been a great year for Pfizer (NYSE:PFE) shareholders. The big drugmaker, along with its German partner BioNTech (NASDAQ:BNTX), became the first . . .
Posted on 1/8/21
Carrum Health Raises $40M in Series A Funding
Carrum Health, a San Francisco, CA-based digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered platform, closed a $40m Series . . .
Posted on 1/8/21
Columbia Care Announces C$130 Million Bought Deal Public Offering
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. . . .
Posted on 1/8/21
Pfizer Stock: A Top Bet for 2021?
If you've spent any amount of time hunting for stocks to buy in 2021, Pfizer (NYSE:PFE) and its recently authorized coronavirus vaccine probably caught your attention.Pfizer . . .
Posted on 1/7/21
SWORD Health Becomes World’s Fastest Growing Virtual Musculoskeletal Solution
NEW YORK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- As physical pain skyrockets from long days at the home office, demand for virtual solutions to musculoskeletal (MSK) . . .
Posted on 1/7/21
Biohaven Acquires Kleo Pharmaceuticals
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the acquisition of the remaining 58% interest of Kleo Pharmaceuticals, Inc. that it did not previously own . . .
Posted on 1/7/21
Aquestive Therapeutics Provides Business Update
WARREN, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ . . .
Posted on 1/7/21
Pacira Reports Record Revenue for 2020 of $429.6 Million
PARSIPPANY, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited . . .
Posted on 1/7/21
Is Pfizer Stock a Buy?
Steve Jobs once told biographer Walter Isaacson, "Deciding what not to do is as important as deciding what to do." Pfizer (NYSE:PFE) has taken that message . . .
Posted on 1/6/21
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines . . .
Posted on 1/6/21
Could Johnson & Johnson Be a Millionaire-Maker Stock?
Investors looking for low volatility and steady, reliable returns have been attracted to Johnson & Johnson (NYSE:JNJ) for decades. The company is a Dividend King, having . . .
Posted on 1/6/21
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
On Monday evening, Dr. Stephen M. Hahn, director of the Food and Drug Administration, and Dr. Peter Marks, the director of the FDA's Center for Biologics . . .
Posted on 1/6/21
Pfizer Launches First Major Rebranding in Over 70 Years
Pfizer (NYSE:PFE) has swallowed its little blue pill.No, we don't mean Viagra. On Tuesday, the company formally discarded its long-standing logo, replacing it with a new . . .
Posted on 1/5/21
ProPhase Labs Offers $5.5 Million of Common Stock and Warrants
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has . . .
Posted on 1/5/21
Quest Diagnostics: A COVID-19 Beneficiary
Summary Quest Diagnostics has effectively captured 24% of a $28Bn market, while earning the loyalty of 11Mn customers digitally by providing low cost, high quality services . . .
Posted on 1/5/21
ADMA Biologics: A Perfect Storm
Summary ADMA has been overly chastised by the market, and its business is performing very well.At its current trading level, ADMA is trading at just about . . .
Posted on 1/5/21
Johnson & Johnson Declares Fresh Dividend; Yield Is 2.6%
The beginning of the year is full of signature events. For many income investors, Johnson & Johnson's (NYSE:JNJ) first dividend declaration is one of them -- . . .
Posted on 1/4/21
Flowonix Medical and SWK Holdings Closes $33M Financing
Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty . . .
Posted on 1/4/21
Dun & Bradstreet - Increasingly Appealing
Summary Dun & Bradstreet has seen solid momentum since going public this summer.The company has seen solid topline sales growth in the first two quarterly earnings . . .
New York
